A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed ...

A genetic test developed by researchers at Broad Clinical Labs and the U.S. Department of Veterans Affairs (VA) is now enabling a large, nationwide clinical trial aimed at improving health care for ...

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

After a cancer diagnosis, patients often have many questions, not only about their treatment but also about what the ...

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 IRVINE, California – ...

New Australian research has highlighted the urgent need for a national framework to guide genetic testing for prostate cancer, with experts warning ...

Impact of a diagnostic bronchoscopy service with embedded reflex molecular testing within an oncology centre in patients with lung cancer: The Bronchiomics study. This is an ASCO Meeting Abstract from ...

We retrospectively reviewed prostate cancer consults within one health care system from November 2, 2021, to January 2, 2023. We compared the proportion of patients who received genomic testing in the ...

CLINTON, Wash. — James DeLong was 51 years old and physically fit when he received devastating news in 2001: prostate cancer. "I'm swallowing hard because, you know, I was like, well, in five years, I ...